Ipilimumab vs Sumatriptan

## Ipilimumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Sumatriptan**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Sumatriptan**: Selective 5-HT1B/1D receptor agonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Sumatriptan — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Sumatriptan — C14H21N3O2S.

**Molecular Weight**: Ipilimumab — N/A; Sumatriptan — 295.4020 g/mol.

**Type**: Ipilimumab — Antibody; Sumatriptan — Small molecule.